Processa Pharmaceuticals Inc (PCSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,156 | -2,303 | -1,097 | -1,856 | -1,223 |
| Depreciation Amortization | 429 | 227 | 64 | 25 | -3 |
| Income taxes - deferred | -771 | -559 | -282 | N/A | N/A |
| Accounts payable and accrued liabilities | 29 | 201 | 54 | 10 | 30 |
| Other Working Capital | 139 | 341 | 246 | 161 | 246 |
| Other Operating Activity | 86 | -140 | -54 | 5 | -30 |
| Operating Cash Flow | $-3,244 | $-2,233 | $-1,069 | $-1,655 | $-979 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -496 | N/A | 1,019 | 1,019 |
| PPE Investments | N/A | N/A | N/A | -21 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 6 | N/A |
| Purchase Sale Intangibles | -22 | -2 | -2 | N/A | N/A |
| Other Investing Activity | -22 | -2 | -2 | 0 | 0 |
| Investing Cash Flow | $-22 | $-498 | $-2 | $1,005 | $1,019 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,580 | N/A |
| Common Stock Issued | 2,965 | 2,856 | N/A | N/A | N/A |
| Other Financing Activity | -122 | -122 | 0 | -155 | -75 |
| Financing Cash Flow | $2,843 | $2,734 | $N/A | $2,425 | $-75 |
| Beginning Cash Position | 2,847 | 2,847 | 2,847 | 1,072 | 1,072 |
| End Cash Position | 2,424 | 2,851 | 1,777 | 2,847 | 1,037 |
| Net Cash Flow | $-423 | $3 | $-1,071 | $1,776 | $-35 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,244 | -2,233 | -1,069 | -1,655 | -979 |
| Capital Expenditure | N/A | N/A | N/A | -21 | N/A |
| Free Cash Flow | -3,244 | -2,233 | -1,069 | -1,675 | -979 |